Evidence map›Paper›PMID 32230836›Full record

ReviewPathogens (Basel, Switzerland)2020

Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys.

Nor Azila Muhammad Azami, Tomohiko Takasaki, Ichiro Kurane, Meng Ling Moi

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Marmosets as models of infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  9. Article
  10. Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Nor Azila Muhammad AzamiUKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Tomohiko TakasakiKanagawa Prefectural Institute of Public Health, Kanagawa 253-0087, Japan.
Ichiro KuraneNational Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Meng Ling MoiInstitute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Kanagawa Prefectural Institute of Public Health · JPNagasaki University · JPNational Institute of Infectious Diseases · JPUniversity Kebangsaan Malaysia Medical Centre · MY

Funding

AMED Research on Emerging and Re-emerging Infectious Diseases NANagasaki University NA
6 · The paper itself

Abstract

Due to the global burden of dengue disease, a vaccine is urgently needed. One of the key points in vaccine development is the development of a robust and reliable animal model of dengue virus infection. Characteristics including the ability to sustain viral replication, demonstration of clinical signs, and immune response that resemble those of human dengue virus infection are vital in animal models. Preclinical studies in vaccine development usually include parameters such as safety evaluation, induction of viremia and antigenemia, immunogenicity, and vaccine effectiveness. Although mice have been used as a model, non-human primates have an advantage over mice because of their relative similarity to humans in their genetic composition and immune responses. This review compares the viremia kinetics and antibody responses of cynomolgus macaques (

Indexed as

animal modelcommon marmosetcynomolgus macaquedengue virusnon-human primatesecondary infectiontamarinvaccine study

Identifiers

PMID32230836
PMCPMC7238212
OpenAlexW3013126375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.